Tag Archives: Blood Pressure – Hypertension

Impact of race on cumulative exposure to antihypertensive medications in dialysis

Theresa I. Shireman, PhD, RPh Professor Director, MS-CR and TL1 Training Program Department of Preventive Medicine & Public Health Department of Health Policy & Management University of Kansas School of Medicine 3901 Rainbow Blvd., MSN 1008 Kansas City, KS 66160Hemodialysis.com Author Interview: Theresa I. Shireman, PhD, RPh
Professor
Director, MS-CR and TL1 Training Program
Department of Preventive Medicine & Public Health
Department of Health Policy & Management
University of Kansas School of Medicine

Hemodialysis.com: What are the main findings of the study?

Dr. Shireman: We found differential exposure over time to three classes of antihypertensives (ACE inhibitors/ARBs, beta-blockers, and calcium channel blockers) among chronic dialysis patients.  Their exposure varied according to race/ethnicity, with African-Americans and Hispanics having lower levels of exposure over time as compared to Caucasians.

Latest update: 22-5-2013 . Thank you for visitng Hemodialysis.com

Not for specific medical advice. Please consult your physician for recommendations and questions. Editor: Marie Benz info@hemodialysis.com